BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12722031)

  • 21. A comparison of corticosteroid and warfarin therapy in IgA nephropathy with crescent formation: preliminary trial.
    Kanno Y; Witt M; Okada H; Nemoto H; Sugahara S; Nakamoto H; Suzuki H
    Clin Exp Nephrol; 2003 Mar; 7(1):48-51. PubMed ID: 14586743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tonsillectomy with methylprednisolone pulse therapy as rescue treatment for steroid-resistant IgA nephropathy in children.
    Kawasaki Y; Suyama K; Abe Y; Ushijima Y; Sakai N; Takano K; Ito M; Hashimoto K; Hosoya M
    Tohoku J Exp Med; 2009 May; 218(1):11-6. PubMed ID: 19398868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study on a predictive marker for evaluating the effectiveness of steroid therapy in IgA nephropathy-significance of extracapillary changes].
    Yamamoto S; Iesato K; Yoshida H; Hori J; Hasegawa R; Ohta Y; Akikusa B; Kondo Y
    Nihon Jinzo Gakkai Shi; 1996 Feb; 38(2):74-83. PubMed ID: 8717309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Steroid therapy in IgA nephropathy: a prospective pilot study in moderate proteinuric cases.
    Kobayashi Y; Fujii K; Hiki Y; Tateno S
    Q J Med; 1986 Oct; 61(234):935-43. PubMed ID: 3628707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.
    Lv J; Zhang H; Chen Y; Li G; Jiang L; Singh AK; Wang H
    Am J Kidney Dis; 2009 Jan; 53(1):26-32. PubMed ID: 18930568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: a long-term controlled trial.
    Lai KN; Lai FM; Ho CP; Chan KW
    Clin Nephrol; 1986 Oct; 26(4):174-80. PubMed ID: 3536231
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Steroid therapy during the early stage of progressive IgA nephropathy. A 10-year follow-up study.
    Kobayashi Y; Hiki Y; Kokubo T; Horii A; Tateno S
    Nephron; 1996; 72(2):237-42. PubMed ID: 8684533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination therapy with or without warfarin and dipyridamole for severe childhood IgA nephropathy: an RCT.
    Shima Y; Nakanishi K; Kaku Y; Ishikura K; Hataya H; Matsuyama T; Honda M; Sako M; Nozu K; Tanaka R; Iijima K; Yoshikawa N;
    Pediatr Nephrol; 2018 Nov; 33(11):2103-2112. PubMed ID: 29987456
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Steroid therapy in IgA nephropathy: a retrospective study in heavy proteinuric cases.
    Kobayashi Y; Fujii K; Hiki Y; Tateno S; Kurokawa A; Kamiyama M
    Nephron; 1988; 48(1):12-7. PubMed ID: 3340251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of antiproteinuric effects of two different combination therapies in children with IgA nephropathy.
    Yagi K; Okada M; Yanagida H; Kuwajima H; Ikeda M; Sugimoto K; Takemura T
    Clin Exp Nephrol; 2003 Dec; 7(4):270-4. PubMed ID: 14712355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of oral steroids with tonsillectomy plus steroid pulse therapy in patients with IgA nephropathy.
    Hoshino Y; Moriyama T; Uchida K; Tsuchiya K; Nitta K
    Clin Exp Nephrol; 2017 Aug; 21(4):617-623. PubMed ID: 27549901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial.
    Yoshikawa N; Honda M; Iijima K; Awazu M; Hattori S; Nakanishi K; Ito H;
    Clin J Am Soc Nephrol; 2006 May; 1(3):511-7. PubMed ID: 17699253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Steroid pulse therapy transiently destroys the discriminative histological structure of tonsils in IgA nephropathy: Tonsillectomy should be performed before or just after steroid pulse therapy.
    Adachi M; Sato M; Miyazaki M; Hotta O; Hozawa K; Sato T; Taguma Y; Katori Y
    Auris Nasus Larynx; 2018 Dec; 45(6):1206-1213. PubMed ID: 29789195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial.
    Hou JH; Le WB; Chen N; Wang WM; Liu ZS; Liu D; Chen JH; Tian J; Fu P; Hu ZX; Zeng CH; Liang SS; Zhou ML; Zhang HT; Liu ZH
    Am J Kidney Dis; 2017 Jun; 69(6):788-795. PubMed ID: 28215945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of steroid-pulse therapy and combined with mizoribine in IgA nephropathy: a randomized controlled trial.
    Masutani K; Tsuchimoto A; Yamada T; Hirakawa M; Mitsuiki K; Katafuchi R; Hirakata H; Kitazono T; Tsuruya K;
    Clin Exp Nephrol; 2016 Dec; 20(6):896-903. PubMed ID: 26758039
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IGA nephropathy - Are intravenous steroid pulses more effective than oral steroids in relapse prevention?
    Laranjinha I; Matias P; Cassis J; Branco P; Ramos S; Barata JD; Weigert A
    Nefrologia (Engl Ed); 2018; 38(4):355-360. PubMed ID: 29129388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination therapy using prednisolone and cyclophosphamide slows the progression of moderately advanced IgA nephropathy.
    Tsuruya K; Harada A; Hirakata H; Mitsuiki K; Johko T; Kondoh H; Takechi S; Fujishima M
    Clin Nephrol; 2000 Jan; 53(1):1-9. PubMed ID: 10661476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclophosphamide pulse therapy in advanced progressive IgA nephropathy.
    Rasche FM; Klotz CH; Czock D; Karges W; Muche R; Jehle PM; Mertz A; Keller F
    Nephron Clin Pract; 2003; 93(4):c131-6. PubMed ID: 12759581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The improvement of renal survival with steroid pulse therapy in IgA nephropathy.
    Katafuchi R; Ninomiya T; Mizumasa T; Ikeda K; Kumagai H; Nagata M; Hirakata H
    Nephrol Dial Transplant; 2008 Dec; 23(12):3915-20. PubMed ID: 18644797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prednisolone and azathioprine in IgA nephropathy - a ten-year follow-up study.
    Goumenos DS; Davlouros P; El Nahas AM; Ahuja M; Shortland JR; Vlachojannis JG; Brown CB
    Nephron Clin Pract; 2003; 93(2):C58-68. PubMed ID: 12616032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.